Abstract Acute renal failure has 50-80% mortality. Currently, treatment options for this life-
threatening disease are limited. Stem cells offer an exciting potential for kidney …

Kidney regeneration is a challenging but promising strategy aimed at reducing the
progression to end-stage renal disease (ESRD) and improving the quality of life of patients …

Recent studies have reported on techniques to mobilize and activate endogenous stem‐
cells in injured kidneys or to introduce exogenous stem cells for tissue repair. Despite many …

Acute kidney injury (AKI) is the rapid onset of decreased kidney function that ultimately
increases mortality and morbidity. Stem cell research is a promising avenue for curative and …

Mesenchymal stem cells (MSC) are non‐haematopoietic cells that are prevalent in the adult
bone marrow but can also be isolated from a variety of other postnatal tissues. MSC are non …

The kidney has a dramatic capacity to regenerate after injury. Whether stem cells are the
source of the epithelial progenitors replacing injured and dying tubular epithelium is …

Chronic kidney disease (CKD) is increasing at the rate of 6–8% per annum in the US alone.
At present, dialysis and transplantation remain the only treatment options. However, there is …

Within the last years, the use of stem cells (embryonic, induced pluripotent stem cells, or
hematopoietic stem cells), Progenitor cells (eg, endothelial progenitor cells), and most …

In the past few years, a number of studies have shown that stem cells can be found in
virtually every organ of the adult organism. The kidney is not an exception, and resident …

The role of embryonal or adult stem cells, in particular bone marrow (BM)-derived stem cells,
in regenerating the kidney after injury has been the subject of intensive investigation. BM …